Provided herein are novel serotonergic psychedelic agents as 5-HT2A agonists, pharmaceutical compositions, use of such compounds in treating psychosis, mental illness and central nervous system (CNS) disorders, and processes for… Click to show full abstract
Provided herein are novel serotonergic psychedelic agents as 5-HT2A agonists, pharmaceutical compositions, use of such compounds in treating psychosis, mental illness and central nervous system (CNS) disorders, and processes for preparing such compounds.
Keywords:
agents ht2a;
psychedelic agents;
ht2a agonists;
treating psychosis;
serotonergic psychedelic;
novel serotonergic
Journal Title: ACS medicinal chemistry letters
Year Published: 2025
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: ACS medicinal chemistry letters
Year Published: 2025
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!